Back
LAW

US imposes visa ban on Indians linked to alleged fentanyl trafficking network

The United States announced visa restrictions on 13 individuals tied to KS International Traders and its owner, alleging involvement in trafficking illicit fentanyl-laced pills to Americans. The action follows earlier sanctions on related entities dating back to 2024 and notes subsequent enforcement actions.

Why It Matters

The move aims to disrupt cross-border illicit fentanyl networks and prevent travel for those involved, reflecting ongoing US-India cooperation on drug enforcement.

Timeline

4 Events

Visa restrictions on KS International Traders and owner (May 12, 2026)

May 12, 2026

The US Department of State announced visa restrictions on 13 individuals associated with KS International Traders and its owner under Section 212(a)(3)(C) of the Immigration and Nationality Act, accusing the firm of selling counterfeit prescriptions laced with illicit fentanyl to Americans.

OFAC sanctions Sutaria and Modi for fentanyl precursor chemicals (April 2026)

April 2026

The US Treasury's OFAC sanctioned Satishkumar Hareshbhai Sutaria and Yuktakumari Ashishkumar Modi for allegedly trading fentanyl precursor chemicals used in producing illicit fentanyl, and facilitating shipments to Mexico and Guatemala, through India-based firms SR Chemicals and Pharmaceuticals and Agrat Chemicals and Pharmaceuticals. They had been arrested in March 2025 in connection with the case.

Arrests of Sutaria and Modi in India (March 2025)

March 2025

Indian authorities arrested Satishkumar Hareshbhai Sutaria and Yuktakumari Ashishkumar Modi in March 2025 in connection with the case.

OFAC sanctions KS International Traders and associates (September 2024)

September 2024

The US Treasury's Office of Foreign Assets Control sanctioned two Indian nationals, Sadiq Abbas Habib Sayyed and Khizar Mohammad Iqbal Shaikh, along with KS International Traders (also known as KS Pharmacy), for involvement with traffickers in the United States and the Dominican Republic to market counterfeit pills laced with fentanyl, fentanyl analogues and methamphetamine.